RxDoctor Payments Data

Heather Sheffield, DO

Family Medicine · Frisco, TXNPI 1205094471

Payments from drug & device makers

$7,251in general payments, 2019–2025

Across 431 payments — averaging $16.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$974
  • Lilly USA, LLC$823
  • AstraZeneca$716
  • Amarin Pharma, Inc.$565
  • Exact Sciences$401
  • Amgen$398
  • plus $3K from 46 others

What the payments were for

  • Food & beverage$7,235100%
  • Entertainment$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,251 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$109,702
Medicare patients
206
Services billed
1,277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin38$51,684
RybelsusSemaglutide26$40,673
OzempicSemaglutide18$32,513
EliquisApixaban21$27,607
FarxigaDapagliflozin Propanediol21$26,252
Synjardy XrEmpagliflozin/Metformin Hcl14$20,884
SynthroidLevothyroxine Sodium23$1,945
Rosuvastatin Calcium179$1,594
Atorvastatin Calcium150$1,192
Levothyroxine Sodium135$1,124
Ezetimibe32$1,094
Metoprolol Succinate81$1,045
Liothyronine Sodium26$1,040
Losartan Potassium80$756
Nebivolol Hcl11$698

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$974$73,18644 claims
Boehringer IngelheimJardiance, Synjardy Xr$368$72,56852 claims
PfizerEliquis$257$27,60721 claims
AstraZenecaFarxiga$716$26,25221 claims
AbbVieSynthroid$291$1,94523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Frisco

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →